Morgan Stanley’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.64M | Sell |
475,280
-21,873
| -4% | -$167K | ﹤0.01% | 4317 |
|
2025
Q1 | $3.11M | Buy |
497,153
+17,827
| +4% | +$111K | ﹤0.01% | 4303 |
|
2024
Q4 | $3.51M | Sell |
479,326
-25,426
| -5% | -$186K | ﹤0.01% | 4289 |
|
2024
Q3 | $5.81M | Sell |
504,752
-58,801
| -10% | -$677K | ﹤0.01% | 3856 |
|
2024
Q2 | $7.45M | Sell |
563,553
-29,902
| -5% | -$395K | ﹤0.01% | 3560 |
|
2024
Q1 | $8.49M | Sell |
593,455
-262,443
| -31% | -$3.75M | ﹤0.01% | 3479 |
|
2023
Q4 | $9.16M | Buy |
+855,898
| New | +$9.16M | ﹤0.01% | 3992 |
|